Related by context. Frequent words. (Click for all words.) 67 castration resistant prostate cancer 66 refractory multiple myeloma 66 metastatic renal cell carcinoma 65 unresectable 65 relapsed multiple myeloma 64 HGS ETR1 64 NSCLC 63 metastatic melanoma 63 acute myelogenous leukemia AML 62 medullary thyroid cancer 62 resistant ovarian cancer 61 chronic HCV 61 hormone refractory prostate cancer 61 cutaneous T cell 60 metastatic colorectal cancer 60 lupus nephritis 60 B CLL 60 BAY #-# 59 metastatic prostate cancer 59 relapsing remitting multiple sclerosis 59 valopicitabine 59 mCRC 59 vandetanib 59 advanced NSCLC 59 glioblastoma multiforme GBM 59 idiopathic pulmonary fibrosis IPF 59 chronic lymphocytic leukemia CLL 58 liver metastases 58 phase IIa 58 severe renal impairment 58 diagnosed multiple myeloma 58 gastrointestinal stromal tumors 58 dacarbazine 58 renal cell carcinoma 58 sunitinib 58 HER2 positive breast cancer 58 RG# [001] 58 Acute Myeloid Leukemia AML 58 soft tissue sarcoma 58 hepatocellular carcinoma HCC 58 TORISEL 58 metastatic pancreatic cancer 58 vinorelbine 58 temsirolimus 58 talactoferrin 58 hepatitis C HCV 58 HER2 positive 58 recurrent ovarian cancer 57 chronic myeloid leukemia CML 57 neoadjuvant chemotherapy 57 myelodysplastic syndromes MDS 57 phase IIb 57 sorafenib 57 TELCYTA 57 aHUS 57 randomized Phase 57 solid tumors 57 myelodysplastic syndrome 57 HRPC 56 ocrelizumab 56 myelofibrosis 56 acute myeloid leukemia 56 glioblastoma 56 chronic HCV infection 56 brain metastases 56 cSSSI 56 plus prednisone 56 relapsing remitting 56 relapsing remitting MS 56 metastatic 56 Bortezomib 56 Yervoy 56 hematological cancers 56 chemotherapy regimens 56 myelodysplastic syndromes 56 GvHD 56 allogeneic stem cell 56 non squamous 56 HCV genotype 1 56 hypoparathyroidism 56 hepatocellular carcinoma 56 Torisel 56 evaluable 56 belinostat 56 SUTENT 55 Phase 2b study 55 voreloxin 55 HER2 negative 55 adjuvant therapy 55 HCV infected 55 systemic lupus erythematosus SLE 55 multiple myeloma 55 acute myeloid leukemia AML 55 Clolar 55 immunomodulator 55 cell lung cancer 55 neuroendocrine tumors 55 refractory peripheral T 55 chemoradiation 55 chemotherapy regimen 55 FOLFIRI